Atlas Trials

IFN-γ Combined With T Cells in the Treatment of Refractory Malignant Pleural Effusion and Ascites

Clinical trial NCT05268172 · UNKNOWN

Trial details

NCT number
NCT05268172
Sponsor
Affiliated Hospital of Jiangnan University
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Pleural Effusion, Malignant
Start date
2022-12-20
Primary completion
2024-12-30
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.